Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Large cell carcinoma of the lung other imaging findings
Introduction
Overview
Overview
Other imaging findings of large cell carcinoma of the lung, include: PET/CT, and pulmonary angiography.[1][2]
Other Imaging Findings
Other Imaging Findings
PET/CT
- PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in the diagnosis of squamous cell carcinoma of the lung, for the following reasons:[1][2]
- General follow-up
- Characterization of treatment response
- Staging modality (in the risk of missing occult disease)
- On PET/CT, findings of large cell carcinoma of the lung, include:[2]
- The CT scan demonstrates abnormalities such as a lung nodule or enlarged lymph nodes. Whereas, the PET scan reveals increased metabolism in structures which contain rapidly growing cancer cells
- Intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and malignant tumor cells.
- On gallium-67-scan, characteristic findings of non-small cell lung cancer, include:[2]
- Gallium uptake is mainly dependent on tumor size (limited practical value)
Pulmonary Angiography
- On pulmonary angiography, findings of large cell carcinoma of the lung, include:[3]
- Evaluation of central pulmonary artery invasion
References
References
- ↑ 1.0 1.1 Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S (2005). “Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging”. Radiology. 236 (3): 1011–9. doi:10.1148/radiol.2363041310. PMID 16014441.
- ↑ 2.0 2.1 2.2 2.3 Steinert HC (2011). “PET and PET-CT of lung cancer”. Methods Mol. Biol. 727: 33–51. doi:10.1007/978-1-61779-062-1_3. PMID 21331927.
- ↑ Delarue NC, Sanders DE, Silverberg SA (1970). “Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer”. Cancer. 26 (6): 1370–8. PMID 5483666.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]